Corruption Category Access to medicines, vaccines and other products

Anti-corruption work relating to the production, supply, distribution, sale and marking of medicines, vaccines and other healthcare products. To prevent theft and safe products, the supply chain should be well designed and have robust checks and balances.


chapter Chapters


research Research

November 2019

Transparency and Professionalism of Drug Reimbursement Policy

Chapter: Slovakia

Slovakia spent a total of €1.1 billion of public money in 2015 on medicines (reimbursed to health insurance companies). This is more than the annual budgets for the Ministries of Defence and Culture combined. The categorisation of medicines is a key part of the decision-making process on drug expenditure. The health care system decides whether…

View Research Paper Overview

November 2019

Sectoral Risk Assessment in Sri Lanka

Chapter: Sri Lanka

Despite an initial energetic start by the Sri Lankan Government with the creation of a number of bodies dealing with the SDGs, such as the Ministry of Sustainable Development and wildlife and the Sustainable Development Council to name a few, there has been little progress in terms of implementation, or of streamlining action across relevant…

View Research Paper Overview

November 2019

Management Of Conflicts Of Interest in Healthcare and Pharmaceutical Industry Cooperation

Chapter: Slovakia

The research explored the potential conflicts of interest faced by doctors working with the pharmaceutical industry and at the same time involved in the categorisation of medicines - deciding which medicines to pay from public health insurance sources (risks of biased drug decisions).

View Research Paper Overview

November 2019

Governance of the Directorate of Drug Administration: Challenges and Way forward

Chapter: Bangladesh

The study assessed the effectiveness of the Government Drug Administration to tackle corruption. The study follows recent measures by the Government to strengthen the capacities of the Drug Administration. These include increasing the workforce in field offices, investing in capacity building, and enhancing the central drug laboratory. Moreover, the Government Drug Administration has taken measures…

View Research Paper Overview

project Projects

May 2020

Mobile Drug Tracking System (MDTS)

The Mobile Drug Tracking System (MDTS) main objective was to increase citizen participation through assisting the citizenry to track pharmaceutical commodities in their local health facilities. It specifically allows citizens, community health workers and hospital management committees to query and monitor stocks. Additionally, it empowers citizens with information and knowledge to hold the governing institutions accountable.

May 2020

Increasing Participation, Accountability, Responsiveness and Transparency (PART): focus on the National Health Insurance Scheme (NHIS) and other MDG-related interventions in the health sector in Ghana’

To achieve improved transparency and accountability in the flow and utilisation of NHIS financial resources leading to improved health service delivery in selected deprived districts by December 2014. The original project was focused on three regions and was financially supported by STAR-Ghana, a multi-donor agency.

February 2020

Stamping out corruption in the Guatemalan health sector

To uncover the alleged wrongdoings of unscrupulous government officials and health care providers.

Policy & Insititutional Change:

Improved enforcement of policies

Behaviour Change:

Anti-Corruption Activism

Community Action

Seeking Redress Against Corruption

November 2019

Vitamin Lab

TI Lithuania launched a social design experiment "Vitamin Lab" to see if changing clinic’s environment indirectly affects the behaviour and attitudes of patients, increases transparency and reduces bribery.

November 2019

Transparency Tools for the Private Sector: Promoting Tools to Improve Transparency Standards in the Pharmaceutical Sector – Multi-Sectorial Transparency Agreement

To promote transparency in the pharmaceutical sector.
Specific objectives:
i) to provide a space for knowledge sharing and networking, with a view of setting up an agenda for multi-stakeholder collaboration and increase transparency in the pharmaceutical sector;
ii) to establish a guide outlining principles to strengthen transparency in the sector, which would support the signing of multi-stakeholder transparency agreements (MTA);
iii) to promote synergies among all relevant actors within the pharmaceutical sector

Behaviour Change:

Seeking Redress Against Corruption

November 2019

Improve Transparency and Accountability in Health Sector under Building Integrity Blocks for Effective Change (BIBEC) Project

The overall objective of BIBEC is to concentrate on building and strengthening a series of mutually supportive and reinforcing integrity blocks to effectively reduce corruption. “Blocks” here imply the key institutions, policy/law, education, training, ethics and values, and above all, the people of the country.

Transparency International Bangladesh's work on health issues mainly includes research and advocacy at local and national levels. The main objective of these activities is to bring about positive changes in policies and practices of concerned authorities in regard to ensuring good governance and integrity in health services.

Policy & Insititutional Change:

Policy Adoption & Amendment

Better Institutional Processes

November 2019

Fight against Illicit Trade of Pharmaceutical Products.

The aim was to raise public awareness of the impact of substandard and falsified medicines (SFM) on their health and advocate for law enforcement operations to increase the seizure of SFM.

Policy & Insititutional Change:

Improved enforcement of policies

Behaviour Change:

Anti-Corruption Activism

Community Action

Seeking Redress Against Corruption

November 2019

Enhancing Community Awareness on the Linkage between Corruption and Human Rights

The Coalition for Accountability and Integrity (AMAN), worked throughout this project on sharing the global knowledge on the linkage between corruption and human rights by compiling a practical assessment for Palestine with focus on the fundamental right to health, and providing community awareness on this linkage and empowering CSOs working on the health right to integrate integrity, transparency, accountability and anti- corruption in their strategies to play an active role in holding officials accountable for corruption and violation of human rights.

Policy & Insititutional Change:

Improved enforcement of policies

Policy Adoption & Amendment

November 2019

Community and Health Provider-driven Social Accountability Intervention (CaPSAI)

The aim of the CaPSAI project is 2-fold:
- Describe and examine how social accountability processes are implemented and operationalized with a focus on understanding behaviours, decision-making processes, and the barriers and facilitators of change, with a view to generalizability;
- Develop more responsive quantitative measures for social accountability and show the relationship between social accountability and uptake of contraceptives and use and other family planning behaviours.

Policy & Insititutional Change:

Better Institutional Processes

Behaviour Change:

Community Action


partner Partners

Global Partners:
World Health Organisation (WHO) United Nations Department for International Development UK (DIFD) Swedish International Development Cooperation Agency (SIDA) Novartis
Regional Partners:

Hospital Health Management Committees

Ministry of Health

NGO or Civil Society Organisation

Community

Governmental Institution

Healthcare Clinics in Lithuania

Business

Individuals or general public

Media

Population Council